Section of General Internal Medicine
Associate Professor of Medicine
Director, Center for Translational and Policy Research of Chronic Diseases
Referring Physician Access Line: 1-877-DOM-2730
|MD||1996||Harvard University ||
|Residency||1999||Stanford University||Internal Medicine
|MPH||2001||Harvard University||Internal Medicine
|Fellowship||2001||Harvard University and Massachusetts General Hospital||General Internal Medicine
Dr. Huang’s broad research interest is in improving the quality of primary care practice. He is a clinical investigator with over a decade of experience studying health services and translational research questions at the intersection of aging, diabetes, and health economics. Dr. Huang has systematically studied complex clinical decisions related to the care of elderly diabetes patients, where clinical trial data from younger, healthier patients must be translated into the care of older, sicker patients. He has employed a wide range of research methods including qualitative interviews, clinical epidemiology, decision analysis, cost-effectiveness analysis, and decision support interventions to better understand patient-provider communication, the impact of patient preferences, the impact of clinical characteristics on the potential benefits of therapies, and the policy implications of individualizing diabetes care.
Dr, Huang's expertise has been recognized with his appointment in 2010 as Senior Advisor, Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.
Diabetes, cardiovascular disease, geriatrics.
- Huang ES, Laiteerapong N, Liu J, John PM, Moffet HH, Karter AJ. Rates of Complications and Mortality in Older Diabetes Patients: The Diabetes and Aging Study. Published online December 2013. JAMA Intern Med.
- Huang ES, Brown SES, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related treatments and complications. Diabetes Care. 2007; 30(10): 2478-2483.
- Huang ES, Gandra N, Zhang Q, Chin MH, Meltzer DO. The effect of functional status and comorbid illness on the expected benefits of intensive glucose control in older people with type 2 diabetes: a decision analysis. Ann Intern Med. 2008; 149(1): 11-19.
- Laiteerapong N, Huang ES. Health care reform and chronic diseases: anticipating the health consequences. JAMA. 2010; 304(8):899-900.
- Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic Control, Complications, and Death in Older Diabetic Patients: The Diabetes & Aging Study. Diabetes Care. 2011; 34(6):1329-1336.